#Novo Nordisk
Total 7 articles
The China obesity drug price war 2026 is heating up as companies slash prices by 80%. Discover how Novo Nordisk and Eli Lilly are responding to local competition.
Amazon Pharmacy now offers Novo Nordisk’s oral Wegovy pill starting at $149 for cash-paying patients. Discover how this impacts the healthcare market.
PRISM by Liabooks
Place your ad in this space
[email protected]
Discover the future of GLP-1 weight-loss pills in 2026. From oral medication to TikTok influencers and telehealth apps, see how the market is changing.
Novo Nordisk (NVO) stock jumped 8% following FDA approval for the oral pill version of its weight-loss drug Wegovy. The move is expected to significantly broaden patient access and intensify competition with Eli Lilly.
The US FDA has approved the first-ever pill form of Novo Nordisk's blockbuster weight-loss drug, Wegovy. Showing comparable results to the injection in trials, the daily pill is set to launch in January 2026.
The FDA has approved a once-daily pill version of Novo Nordisk's blockbuster weight-loss drug Wegovy, offering a new option versus the weekly shot and escalating competition with Eli Lilly.
PRISM by Liabooks
Place your ad in this space
[email protected]